American Well [AMWL] vs Ge Healthcare [GEHC] Detailed Stock Comparison
American Well
NYSE
Loading...
Ge Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: American Well wins in 8 metrics, Ge Healthcare wins in 10 metrics, with 0 ties. Ge Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | American Well | Ge Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.50 | 14.83 | American Well |
| Price-to-Book Ratio | 0.40 | 3.40 | American Well |
| Debt-to-Equity Ratio | 2.17 | 107.67 | American Well |
| PEG Ratio | 0.01 | 1.16 | American Well |
| EV/EBITDA | 0.92 | 10.96 | American Well |
| Profit Margin (TTM) | -46.16% | 11.22% | Ge Healthcare |
| Operating Margin (TTM) | -28.74% | 14.62% | Ge Healthcare |
| EBITDA Margin (TTM) | N/A | 14.62% | N/A |
| Return on Equity | -37.62% | 25.80% | Ge Healthcare |
| Return on Assets (TTM) | -17.93% | 5.77% | Ge Healthcare |
| Free Cash Flow (TTM) | $-142.56M | $1.55B | Ge Healthcare |
| Dividend Yield | N/A | 0.24% | N/A |
| 1-Year Return | -11.98% | -11.00% | Ge Healthcare |
| Price-to-Sales Ratio (TTM) | 0.42 | 1.66 | American Well |
| Enterprise Value | $-87.96M | $40.27B | Ge Healthcare |
| EV/Revenue Ratio | -0.33 | 2.02 | American Well |
| Gross Profit Margin (TTM) | 56.07% | 39.65% | American Well |
| Revenue per Share (TTM) | $17 | $44 | Ge Healthcare |
| Earnings per Share (Diluted) | $-8.03 | $4.88 | Ge Healthcare |
| Beta (Stock Volatility) | 1.28 | 1.28 | Ge Healthcare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
American Well vs Ge Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| American Well | 3.87% | 1.16% | -17.69% | 0.87% | -20.23% | -0.85% |
| Ge Healthcare | 2.17% | 2.71% | 7.05% | 5.84% | -10.65% | -3.38% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| American Well | -11.98% | -91.94% | -98.48% | -98.48% | -98.48% | -98.48% |
| Ge Healthcare | -11.00% | 33.47% | 33.47% | 33.47% | 33.47% | 33.47% |
Performance & Financial Health Analysis: American Well vs Ge Healthcare
| Metric | AMWL | GEHC |
|---|---|---|
| Market Information | ||
| Market Cap | $112.74M | $34.58B |
| Market Cap Category | Micro cap | Large cap |
| 10 Day Avg. Volume | 58,190 | 2,646,550 |
| 90 Day Avg. Volume | 63,940 | 3,583,470 |
| Last Close | $6.98 | $75.73 |
| 52 Week Range | $6.09 - $12.95 | $57.65 - $94.80 |
| % from 52W High | -46.10% | -20.12% |
| All-Time High | $875.00 (Jan 25, 2021) | $94.80 (Feb 10, 2025) |
| % from All-Time High | -99.20% | -20.12% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.04% |
| Quarterly Earnings Growth | 0.13% | 0.14% |
| Financial Health | ||
| Profit Margin (TTM) | -0.46% | 0.11% |
| Operating Margin (TTM) | -0.29% | 0.15% |
| Return on Equity (TTM) | -0.38% | 0.26% |
| Debt to Equity (MRQ) | 2.17 | 107.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $17.56 | $21.27 |
| Cash per Share (MRQ) | $13.56 | $8.19 |
| Operating Cash Flow (TTM) | $-75,621,000 | $2.00B |
| Levered Free Cash Flow (TTM) | $-16,141,000 | $1.58B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.24% |
| Last 12-Month Dividend | N/A | $0.18 |
Valuation & Enterprise Metrics Analysis: American Well vs Ge Healthcare
| Metric | AMWL | GEHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.50 | 14.83 |
| Forward P/E | -0.91 | 15.50 |
| PEG Ratio | 0.01 | 1.16 |
| Price to Sales (TTM) | 0.42 | 1.66 |
| Price to Book (MRQ) | 0.40 | 3.40 |
| Market Capitalization | ||
| Market Capitalization | $112.74M | $34.58B |
| Enterprise Value | $-87,956,408 | $40.27B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -0.33 | 2.02 |
| Enterprise to EBITDA | 0.92 | 10.96 |
| Risk & Other Metrics | ||
| Beta | 1.28 | 1.28 |
| Book Value per Share (MRQ) | $17.56 | $21.27 |
Financial Statements Comparison: American Well vs Ge Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMWL | GEHC |
|---|---|---|
| Revenue/Sales | $66.83M | $4.78B |
| Cost of Goods Sold | $31.57M | $2.77B |
| Gross Profit | $35.26M | $2.01B |
| Research & Development | $22.10M | $344.00M |
| Operating Income (EBIT) | $-30.41M | $628.00M |
| EBITDA | $-33.32M | $842.00M |
| Pre-Tax Income | $-17.01M | $692.00M |
| Income Tax | $568,000 | $104.00M |
| Net Income (Profit) | $-18.36M | $588.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMWL | GEHC |
|---|---|---|
| Cash & Equivalents | $222.41M | $2.45B |
| Total Current Assets | $311.50M | $9.74B |
| Total Current Liabilities | $106.73M | $9.97B |
| Long-Term Debt | $3.57M | $7.06B |
| Total Shareholders Equity | $305.77M | $9.42B |
| Retained Earnings | $-1.98B | $3.81B |
| Property, Plant & Equipment | $6.72M | $369.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMWL | GEHC |
|---|---|---|
| Operating Cash Flow | $-5.33M | $509.00M |
| Capital Expenditures | $-9,000 | $-152.00M |
| Free Cash Flow | $-25.12M | $98.00M |
| Debt Repayment | N/A | $-257.00M |
| Common Stock Repurchase | $-1,000 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AMWL | GEHC |
|---|---|---|
| Shares Short | 162,811 | 8.40M |
| Short Ratio | 2.19 | 1.96 |
| Short % of Float | 0.01% | 0.02% |
| Average Daily Volume (10 Day) | 58,190 | 2,646,550 |
| Average Daily Volume (90 Day) | 63,940 | 3,583,470 |
| Shares Outstanding | 15.57M | 456.96M |
| Float Shares | 12.35M | 455.28M |
| % Held by Insiders | 0.06% | 0.00% |
| % Held by Institutions | 0.44% | 0.87% |
Dividend Analysis & Yield Comparison: American Well vs Ge Healthcare
| Metric | AMWL | GEHC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.18 |
| Last 12-Month Dividend Yield | N/A | 0.24% |
| 3-Year Avg Annual Dividend | N/A | $0.11 |
| 3-Year Avg Dividend Yield | N/A | 0.04% |
| 3-Year Total Dividends | N/A | $0.33 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |